CBRS · Cerebras Systems

The thesis

Cerebras Systems is more likely than not to beat the S&P 500 over the next three months. On 12 November 2026 it guided fourth-quarter core revenue (its adjusted revenue measure) to $310–330 million, against a $271.1 million consensus cited by Benzinga. That came after the shares had already fallen 55.4% in three months. The question now is whether the market believes that guidance and whether the $26.1 billion backlog turns into revenue on schedule. Delivery news before the fourth-quarter report, and the report itself, will decide it.

The rating is Medium because the guidance surprise is large and dated, while the risks are just as concrete. Most of the revenue depends on one customer. Pre-IPO shareholders are now free to sell, and GAAP (generally accepted accounting principles) margins fell by half from a year earlier. The shares closed at $97.75 on 12 November 2026, before the report. TheStreet's live coverage reported them up about 12% in after-hours trading that evening.

At that close, the price reflected deep doubt about the OpenAI-driven ramp. The shares were well below the $185 IPO price from May 2026 and far under the 50-day average of $152.65.

Bullish and bearish views on Cerebras Systems Inc.

The bull case on Cerebras Systems Inc. (CBRS), in brief: fourth-quarter guidance far above consensus. The bear case: one customer carries the case.

Bull case

• Fourth-quarter guidance far above consensus. On 12 November 2026 the company guided fourth-quarter core revenue to $310–330 million, against a $271.1 million estimate. It also guided core gross margin to 47%–49% and core operating margin to between −1% and 1%.
• Full-year outlook raised a second time. The 2026 core revenue range moved to $940–960 million from $880–890 million on 12 November 2026, against an $887.0 million estimate. The company had already raised it from $855–865 million in August.
• Cloud revenue is scaling fast. Third-quarter GAAP cloud and services revenue was $141.9 million, up 265% from $38.9 million a year earlier, per the 12 November 2026 release. Total core revenue grew 70% to $230.9 million.
• Backlog and cash cover years of work. Remaining performance obligations, meaning contracted revenue not yet recognised, stood at $26.1 billion on 30 September 2026. Cash, restricted cash and short-term investments were $7.8 billion.
• New customers widen the base. The 12 November 2026 release names Oracle, which will run Cerebras inference in Oracle Cloud Infrastructure in 2027, and an unnamed top-three hyperscaler. Bilt chose Cerebras for its Neighborhood OS on 10 November 2026. CEO Andrew Feldman said the company expects to triple revenue in 2027.

Bear case

• One customer carries the case. MarketScreener reported on 13 August 2026 that growth and valuation rest on a multiyear $20 billion OpenAI deal. The 12 November 2026 release flags OpenAI's Master Relationship Agreement in its risk factors but gives no customer share.
• GAAP results missed and margins halved. Third-quarter GAAP revenue of $210.8 million missed the $214.7 million estimate. GAAP gross margin fell to 20.0% from 40.6% a year earlier, and the net loss widened to $161.2 million from $22.2 million.
• Heavy spending and stock compensation. In the first nine months of 2026, operating cash use was $388.9 million and equipment purchases were $1,046.1 million, per the 12 November 2026 release. Stock-based compensation over the same period was $541.7 million.
• Insiders sold into the decline. SEC Form 4 filings show four executives selling under Rule 10b5-1 plans, which are trading plans set in advance. The chief operating officer sold 396,000 shares at an average of $204.04 on 29 September 2026. The chief technology officer sold 120,000 at $208.97 on 25 September 2026 and 60,000 at $115.79 on 27 October 2026. The CFO sold 32,500 at $203.53 on 29 September 2026.
• Competition from in-house chips. Bloomberg reported on 9 November 2026 that Google is building specialised versions of its AI chips. That raises the bar for outside inference hardware at the largest buyers.

Price setup

The shares closed at $97.75 on 12 November 2026, down 3.29% that session, ahead of the report released at 4:05 p.m. Eastern. Adjusted daily closes show a 55.4% fall over three months. The 50-day average was $152.65 on 12 November 2026.

Form 4 sale prices trace how fast the shares fell. Executives sold near $204–209 in late September 2026 and near $116 on 27 October 2026. The IPO price was $185.

Two price tests matter. The first is whether the reported after-hours gain survives the 13 November 2026 regular session. The second is whether the shares recover toward the 50-day average as it declines. Moves of this size are normal for the stock: TipRanks reported that options priced a 13.7% move around the 12 November 2026 report.

Catalysts ahead

• 17 November 2026: Cerebras at the TomorrowX Summit. A company investor event where management can update data-center delivery timing and customer additions behind the 2027 tripling goal.
• 9 December 2026: Cerebras at the Barclays Global Technology Conference. Management's first public check on fourth-quarter progress against the $310–330 million core revenue guide.
• ~25 February 2027 (est.): Q4 and full-year 2026 report. Shows whether core revenue reached $310–330 million at a 47%–49% core gross margin, and sets the first dollar outlook for 2027.

Elapsed catalysts

• 13 November 2026: First full trading session after the Q3 2026 report. Shows whether the roughly 12% after-hours gain TheStreet reported on 12 November 2026 holds once regular trading prices in the raised guidance. (passed)

What would change the view

A daily close below $85, well under the $97.75 close of 12 November 2026 that preceded the raised guidance, which would show the market rejecting the outlook. Fourth-quarter 2026 core revenue below the $310 million low end of the guide would also break the case.

The risks this note tracks, each with what would confirm it:

• OpenAI demand or payment timing slips, cutting into revenue that rests on a multiyear $20 billion agreement. Confirmed by: a reduced or rescheduled OpenAI commitment, or remaining performance obligations falling below $26.1 billion at the Q4 2026 report.
• Data-center capacity arrives late, pushing backlog conversion and the 2027 tripling goal out. Confirmed by: management delays any part of the 700 gross megawatts contracted for delivery by the end of 2027, or delays CS-4 full production.
• Pre-IPO and insider share sales add supply as lock-up tranches are released. Confirmed by: new Form 4 filings showing large executive or director open-market sales, or a secondary offering by existing holders.
• Spending outruns funding and forces an equity raise that dilutes shareholders. Confirmed by: an equity offering or a large new debt facility, or cash and short-term investments falling well below $7.8 billion at the Q4 report.
• Hyperscalers' in-house chips take inference work that would otherwise go to Cerebras. Confirmed by: the unnamed top-three hyperscaler or Oracle scaling back or delaying its Cerebras deployment.

What it trades with

Cerebras trades with the AI infrastructure group: GPU cloud providers, AI chipmakers and data-center suppliers. Benzinga reported on 11 November 2026 that fabless chip stocks rose after CoreWeave's third-quarter results and guidance. Cerebras was on the same 12 November 2026 earnings volatility list as Nebius, Cisco and Applied Materials. A broad pullback in AI spending sentiment would weigh on the shares whatever the company reports.

The company-specific driver is OpenAI's demand and how fast Cerebras can bring data-center capacity online: 700 gross megawatts are contracted for delivery by the end of 2027. That makes the shares more sensitive to OpenAI's funding and compute plans than to Nvidia's product cycle.